Journal Article DKFZ-2018-00625

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
An efficient protocol for in vivo labeling of proliferating epithelial cells.

 ;  ;  ;  ;

2018
Elsevier Science Amsterdam [u.a.]

Journal of immunological methods 457, 82 - 86 () [10.1016/j.jim.2018.03.015]
 GO

This record in other databases:  

Please use a persistent id in citations: doi:

Abstract: The study of organogenesis, tissue-homeostasis and regeneration requires the precise assessment of in vivo cell proliferation. To this end a host of methods have been developed to detect and quantify DNA synthesis in proliferating cells. These include cell labeling with various nucleotide analogues and fluorescence reporter-based animal models with each method presenting its idiosyncratic shortcomings. Quantitative assessment of epithelial cell turnover has been partly hampered due to their variable and limited in vivo accessibility and the requirement for harsher isolation procedures to procure single cells for FACS analysis. Here, we report a reliable protocol to study in vivo cell proliferation of epithelial cells in mice by repeatedly injecting EdU intravenously for an extended 12-day period. EdU incorporation was quantitated ex vivo by FACS after tissue dissociation in order to obtain single epithelial cell suspensions. As a lead population, we analyzed thymic epithelial cells (TECs), where we were able to label compartmentalized TEC subsets to saturation without apparent toxic effects on the thymus architecture or stress-sensitive TEC lineage differentiation. The data is in concordance with the prevailing model of medullary TEC terminal differentiation that includes the post-Aire stage. The same protocol was successfully applied to epithelial cells of various other organs - skin, lymph node, kidney and small intestine - tissues with widely varying frequencies and rates of proliferating epithelial cells.

Classification:

Contributing Institute(s):
  1. Entwicklungsimmunologie (D090)
  2. Genetik der Hautkarcinogenese (A110)
Research Program(s):
  1. 314 - Tumor immunology (POF3-314) (POF3-314)

Appears in the scientific report 2018
Database coverage:
Medline ; BIOSIS Previews ; Current Contents - Life Sciences ; Ebsco Academic Search ; IF < 5 ; JCR ; NCBI Molecular Biology Database ; NationallizenzNationallizenz ; SCOPUS ; Science Citation Index ; Science Citation Index Expanded ; Thomson Reuters Master Journal List ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2018-06-07, last modified 2024-02-29



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)